Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' p... Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. Show more
CAMBRIDGE, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
– Agios Expects to Receive $905 Million Payment from Royalty Pharma and $200 Million Payment from Servier in Q3 2024; Payments Increase Agios’ Pro-Forma Cash Position as of June 30, 2024, to $1.7...
– Reported Positive Topline Data from Phase 3 ENERGIZE-T Study; Expect to File sNDA Based on ENERGIZE and ENERGIZE-T Studies Encompassing All Thalassemia Subtypes by End of 2024 – – Announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.69 | 3.75555555556 | 45 | 49.36 | 42.97 | 330649 | 45.35156898 | CS |
4 | 4.14 | 9.72972972973 | 42.55 | 50.35 | 40.795 | 500915 | 45.09403266 | CS |
12 | 16.38 | 54.0415704388 | 30.31 | 50.35 | 27.14 | 642259 | 38.97032487 | CS |
26 | 19.61 | 72.4150664697 | 27.08 | 50.35 | 19.795 | 671338 | 31.54287661 | CS |
52 | 1.13 | 2.48024582968 | 45.56 | 50.98 | 16.75 | 592411 | 29.61192365 | CS |
156 | 8.42 | 22.0015678077 | 38.27 | 62.155 | 16.75 | 647953 | 36.62764518 | CS |
260 | 0 | 0 | 0 | 47.09 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.